14 | | - | Vogel, Pena–Melnyk, Cullison, Alston, Bagnall, Bhandari, Guzzone, Hill, |
---|
15 | | - | Hutchinson, S. Johnson, Kaiser, Kerr, Lopez, Martinez, Rosenberg, |
---|
16 | | - | White Holland, Woods, and Woorman |
---|
29 | 20 | | |
---|
30 | 21 | | FOR the purpose of requiring, beginning on a certain date, the Maryland Medical 4 |
---|
31 | 22 | | Assistance Program to provide coverage for self–measured blood pressure 5 |
---|
32 | 23 | | monitoring for certain eligible Program recipients; requiring the Program to develop 6 |
---|
33 | 24 | | and implement a certain education campaign; and generally relating to 7 |
---|
34 | 25 | | self–measured blood pressure monitoring under the Maryland Medical Assistance 8 |
---|
35 | 26 | | Program. 9 |
---|
36 | 27 | | |
---|
37 | 28 | | BY repealing and reenacting, without amendments, 10 |
---|
38 | 29 | | Article – Health – General 11 |
---|
39 | 30 | | Section 15–101(h), (j), and (l) and 15–103(a)(1) 12 |
---|
40 | 31 | | Annotated Code of Maryland 13 |
---|
41 | 32 | | (2023 Replacement Volume and 2024 Supplement) 14 |
---|
42 | 33 | | |
---|
43 | 34 | | BY repealing and reenacting, with amendments, 15 |
---|
44 | 35 | | Article – Health – General 16 |
---|
45 | 36 | | Section 15–103(a)(2)(xxiii) and (xxiv) 17 |
---|
46 | 37 | | Annotated Code of Maryland 18 |
---|
47 | 38 | | (2023 Replacement Volume and 2024 Supplement) 19 |
---|
81 | | - | (xxiii) Beginning on July 1, 2025, shall provide, subject to the 21 |
---|
82 | | - | limitations of the State budget, and as permitted by federal law, coverage for biomarker 22 |
---|
83 | | - | testing in accordance with § 15–859 of the Insurance Article; [and] 23 |
---|
| 79 | + | (XXV) BEGINNING ON JANUARY 1, 2026, SHALL PROVIDE , 19 |
---|
| 80 | + | SUBJECT TO THE LIMITAT IONS OF THE STATE BUDGET , AND AS PERMITTED BY 20 |
---|
| 81 | + | FEDERAL LAW , COVERAGE FOR SELF –MEASURED BLOOD PRESS URE MONITORING 21 |
---|
| 82 | + | FOR ELIGIBLE PROGRAM RECIPIENTS IN ACCORDANCE WITH § 15–141.6 OF THIS 22 |
---|
| 83 | + | SUBTITLE. 23 |
---|
98 | | - | (A) (1) IN THIS SECTION THE FOLLOWING WORDS HAVE THE MEANINGS 1 |
---|
99 | | - | INDICATED. 2 |
---|
100 | | - | |
---|
101 | | - | (2) “ELIGIBLE PROGRAM, “ELIGIBLE PROGRAM RECIPIENT” MEANS 3 |
---|
102 | | - | A PROGRAM RECIPIENT WHO : 4 |
---|
103 | | - | |
---|
104 | | - | (I) (1) IS PREGNANT; 5 |
---|
105 | | - | |
---|
106 | | - | (II) (2) IS POSTPARTUM ; OR 6 |
---|
107 | | - | |
---|
108 | | - | (III) (3) HAS BEEN DIAGNOSED WITH : 7 |
---|
109 | | - | |
---|
110 | | - | 1. (I) CHRONIC KIDNEY DISEAS E; 8 |
---|
111 | | - | |
---|
112 | | - | 2. (II) DIABETES; 9 |
---|
113 | | - | |
---|
114 | | - | 3. (III) HEART DISEASE; OR 10 |
---|
115 | | - | |
---|
116 | | - | 4. (IV) A CARDIOMETABOLIC DISE ASE. 11 |
---|
117 | | - | |
---|
118 | | - | (3) “HEALTH CARE PROVIDER ” MEANS: 12 |
---|
119 | | - | |
---|
120 | | - | (I) A PERSON WHO IS LICENS ED, CERTIFIED, OR OTHERWISE 13 |
---|
121 | | - | AUTHORIZED UNDER THE HEALTH OCCUPATIONS ARTICLE TO PROVIDE HE ALTH 14 |
---|
122 | | - | CARE IN THE ORDINARY COURSE OF BUSINESS O R PRACTICE OF A PROF ESSION, OR 15 |
---|
123 | | - | IN AN APPROVED EDUCA TION OR TRAINING PRO GRAM; OR 16 |
---|
124 | | - | |
---|
125 | | - | (II) A COMMUNITY HEALTH WOR KER CERTIFIED UNDER TITLE 17 |
---|
126 | | - | 13, SUBTITLE 37 OF THIS ARTICLE. 18 |
---|
127 | | - | |
---|
128 | | - | (B) THE PROGRAM SHALL PROVIDE COVERAGE FOR SELF –MEASURED 19 |
---|
129 | | - | BLOOD PRESSURE MONIT ORING FOR ALL ELIGIB LE PROGRAM RECIPIENTS , 20 |
---|
130 | | - | INCLUDING: 21 |
---|
131 | | - | |
---|
132 | | - | (1) THE PROVISION OF VALI DATED HOME BLOOD PRE SSURE 22 |
---|
133 | | - | MONITORS; AND 23 |
---|
134 | | - | |
---|
135 | | - | (2) REIMBURSEMENT OF HEAL TH CARE PROVIDER AND OTHER STAFF 24 |
---|
136 | | - | TIME USED FOR PATIEN T TRAINING, TRANSMISSION OF BLOO D PRESSURE DATA , 25 |
---|
137 | | - | INTERPRETATION OF BL OOD PRESSURE READING S AND REPORTING , REMOTE 26 |
---|
138 | | - | PATIENT MONITORING , AND THE DELIVERY OF CO–INTERVENTIONS , INCLUDING 27 |
---|
139 | | - | EDUCATIONAL MATERIAL S OR CLASSES. 28 |
---|
140 | | - | 4 HOUSE BILL 553 |
---|
141 | | - | |
---|
142 | | - | |
---|
143 | | - | (C) THE PROGRAM SHALL DEVELOP AND IMPLEMENT AN EDU CATION 1 |
---|
144 | | - | CAMPAIGN TO INFORM E LIGIBLE PROGRAM RECIPIENTS AN D HEALTH CARE 2 |
---|
145 | | - | PROVIDERS ABOUT THE BENEFITS AND USAGE O F BLOOD PRESSURE MON ITORING 3 |
---|
146 | | - | TECHNOLOGY AND THE A VAILABILITY OF ASSIS TANCE WITH SETUP AND 4 |
---|
147 | | - | TROUBLESHO OTING. 5 |
---|
148 | | - | |
---|
149 | | - | (D) ON OR BEFORE DECEMBER 1 EACH YEAR, BEGINNING IN 2027, THE 6 |
---|
150 | | - | DEPARTMENT SHALL SUBM IT A REPORT TO THE SENATE FINANCE COMMITTEE AND 7 |
---|
151 | | - | THE HOUSE HEALTH AND GOVERNMENT OPERATIONS COMMITTEE, IN 8 |
---|
152 | | - | ACCORDANCE WITH § 2–1257 OF THE STATE GOVERNMENT ARTICLE, THAT 9 |
---|
153 | | - | INCLUDES: 10 |
---|
154 | | - | |
---|
155 | | - | (1) THE TOTAL NUMBER OF E LIGIBLE PROGRAM RECIPIENTS WH O 11 |
---|
156 | | - | RECEIVED BLOOD PRESS URE MONITORS UNDER T HIS SECTION DURING T HE 12 |
---|
157 | | - | IMMEDIATELY PRECEDIN G 12–MONTH PERIOD ; 13 |
---|
158 | | - | |
---|
159 | | - | (2) THE OUTCOMES ASSOCIAT ED WITH THE USE OF T HE HOME BLOOD 14 |
---|
160 | | - | PRESSURE MONITORS UNDER THIS SECTION ; AND 15 |
---|
161 | | - | |
---|
162 | | - | (3) ANY COST SAVINGS ACHI EVED BY THE PROGRAM DURING THE 16 |
---|
163 | | - | IMMEDIATELY PRECEDIN G FISCAL YEAR ASSOCI ATED WITH THE USE OF THE HOME 17 |
---|
164 | | - | BLOOD PRESSURE MONIT ORS DISTRIBUTED IN A CCORDANCE WITH THIS SECTION. 18 |
---|
165 | | - | |
---|
166 | | - | SECTION 2. AND BE IT FURTHER ENA CTED, That this Act shall take effect July 19 |
---|
167 | | - | 1, 2025. 20 |
---|
| 95 | + | (II) IS POSTPARTUM ; OR 30 HOUSE BILL 553 3 |
---|
| 99 | + | (III) HAS BEEN DIAGNOSED WI TH: 1 |
---|
| 100 | + | |
---|
| 101 | + | 1. CHRONIC KIDNEY DISEAS E; 2 |
---|
| 102 | + | |
---|
| 103 | + | 2. DIABETES; 3 |
---|
| 104 | + | |
---|
| 105 | + | 3. HEART DISEASE; OR 4 |
---|
| 106 | + | |
---|
| 107 | + | 4. A CARDIOMETABOLIC DISE ASE. 5 |
---|
| 108 | + | |
---|
| 109 | + | (3) “HEALTH CARE PROVIDER ” MEANS: 6 |
---|
| 110 | + | |
---|
| 111 | + | (I) A PERSON WHO IS LICENS ED, CERTIFIED, OR OTHERWISE 7 |
---|
| 112 | + | AUTHORIZED UNDER THE HEALTH OCCUPATIONS ARTICLE TO PROVIDE HE ALTH 8 |
---|
| 113 | + | CARE IN THE ORDINARY COURSE OF BUSINESS O R PRACTICE OF A PROFES SION, OR 9 |
---|
| 114 | + | IN AN APPROVED EDUCA TION OR TRAINING PRO GRAM; OR 10 |
---|
| 115 | + | |
---|
| 116 | + | (II) A COMMUNITY HEALTH WOR KER CERTIFIED UNDER TITLE 11 |
---|
| 117 | + | 13, SUBTITLE 37 OF THIS ARTICLE. 12 |
---|
| 118 | + | |
---|
| 119 | + | (B) THE PROGRAM SHALL PROVIDE COVERAGE FOR SELF –MEASURED 13 |
---|
| 120 | + | BLOOD PRESSURE MONIT ORING FO R ALL ELIGIBLE PROGRAM RECIPIENTS , 14 |
---|
| 121 | + | INCLUDING: 15 |
---|
| 122 | + | |
---|
| 123 | + | (1) THE PROVISION OF VALI DATED HOME BLOOD PRE SSURE 16 |
---|
| 124 | + | MONITORS; AND 17 |
---|
| 125 | + | |
---|
| 126 | + | (2) REIMBURSEMENT OF HEAL TH CARE PROVIDER AND OTHER STAFF 18 |
---|
| 127 | + | TIME USED FOR PATIEN T TRAINING, TRANSMISSION OF BLOO D PRESSURE DATA , 19 |
---|
| 128 | + | INTERPRETATI ON OF BLOOD PRESSURE READINGS AND REPORTI NG, REMOTE 20 |
---|
| 129 | + | PATIENT MONITORING , AND THE DELIVERY OF CO–INTERVENTIONS , INCLUDING 21 |
---|
| 130 | + | EDUCATIONAL MATERIAL S OR CLASSES. 22 |
---|
| 131 | + | |
---|
| 132 | + | (C) THE PROGRAM SHALL DEVELOP AND IM PLEMENT AN EDUCATION 23 |
---|
| 133 | + | CAMPAIGN TO INFORM E LIGIBLE PROGRAM RECIPIE NTS AND HEALTH CARE 24 |
---|
| 134 | + | PROVIDERS ABOUT THE BENEFITS AND USAGE O F BLOOD PRESSURE MON ITORING 25 |
---|
| 135 | + | TECHNOLOGY AND THE A VAILABILITY OF ASSIS TANCE WITH SETUP AND 26 |
---|
| 136 | + | TROUBLESHOOTING . 27 |
---|
| 137 | + | |
---|
| 138 | + | (D) ON OR BEFORE DECEMBER 1 EACH YEAR, BEGINNING IN 2027, THE 28 |
---|
| 139 | + | DEPARTMENT SHALL SUBM IT A REPORT TO THE SENATE FINANCE COMMITTEE AND 29 |
---|
| 140 | + | THE HOUSE HEALTH AND GOVERNMENT OPERATIONS COMMITTEE, IN 30 4 HOUSE BILL 553 |
---|
173 | | - | Approved: |
---|
174 | | - | ________________________________________________________________________________ |
---|
175 | | - | Governor. |
---|
176 | | - | ________________________________________________________________________________ |
---|
177 | | - | Speaker of the House of Delegates. |
---|
178 | | - | ________________________________________________________________________________ |
---|
179 | | - | President of the Senate. |
---|
| 143 | + | ACCORDANCE WITH § 2–1257 OF THE STATE GOVERNMENT ARTICLE, THAT 1 |
---|
| 144 | + | INCLUDES: 2 |
---|
| 145 | + | |
---|
| 146 | + | (1) THE TOTAL NUMBER OF E LIGIBLE PROGRAM RECIPIENTS WH O 3 |
---|
| 147 | + | RECEIVED BLOOD PRESS URE MONITORS UNDER THIS SECTION DURING THE 4 |
---|
| 148 | + | IMMEDIATELY PRECEDIN G 12–MONTH PERIOD ; 5 |
---|
| 149 | + | |
---|
| 150 | + | (2) THE OUTCOMES ASSOCIAT ED WITH THE USE OF T HE HOME BLOOD 6 |
---|
| 151 | + | PRESSURE MONITORS UN DER THIS SECTION ; AND 7 |
---|
| 152 | + | |
---|
| 153 | + | (3) ANY COST SAVINGS ACHI EVED BY THE PROGRAM DURING THE 8 |
---|
| 154 | + | IMMEDIATELY PRECEDING FISCAL YEA R ASSOCIATED WITH TH E USE OF THE HOME 9 |
---|
| 155 | + | BLOOD PRESSURE MONIT ORS DISTRIBUTED IN A CCORDANCE WITH THIS SECTION. 10 |
---|
| 156 | + | |
---|
| 157 | + | SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect July 11 |
---|
| 158 | + | 1, 2025. 12 |
---|
| 159 | + | |
---|